George J Netto MD
George J Netto MD
UAB University of Alabama at Birmingham
Verified email at
Cited by
Cited by
Detection of circulating tumor DNA in early-and late-stage human malignancies
C Bettegowda, M Sausen, RJ Leary, I Kinde, Y Wang, N Agrawal, ...
Science translational medicine 6 (224), 224ra24-224ra24, 2014
TERT promoter mutations occur frequently in gliomas and a subset of tumors derived from cells with low rates of self-renewal
PJ Killela, ZJ Reitman, Y Jiao, C Bettegowda, N Agrawal, LA Diaz, ...
Proceedings of the National Academy of Sciences 110 (15), 6021-6026, 2013
Immune inhibitory molecules LAG-3 and PD-1 synergistically regulate T-cell function to promote tumoral immune escape
SR Woo, ME Turnis, MV Goldberg, J Bankoti, M Selby, CJ Nirschl, ...
Cancer research 72 (4), 917-927, 2012
In breast carcinoma tissue, immature dendritic cells reside within the tumor, whereas mature dendritic cells are located in peritumoral areas
D Bell, P Chomarat, D Broyles, G Netto, GM Harb, S Lebecque, ...
The Journal of experimental medicine 190 (10), 1417-1426, 1999
Androgen-induced TOP2B-mediated double-strand breaks and prostate cancer gene rearrangements
MC Haffner, MJ Aryee, A Toubaji, DM Esopi, R Albadine, B Gurel, ...
Nature genetics 42 (8), 668-675, 2010
LAG-3 regulates CD8+ T cell accumulation and effector function in murine self- and tumor-tolerance systems
JF Grosso, CC Kelleher, TJ Harris, CH Maris, EL Hipkiss, A De Marzo, ...
The Journal of clinical investigation 117 (11), 3383-3392, 2007
Global 5-hydroxymethylcytosine content is significantly reduced in tissue stem/progenitor cell compartments and in human cancers
MC Haffner, A Chaux, AK Meeker, DM Esopi, J Gerber, LG Pellakuru, ...
Oncotarget 2 (8), 627, 2011
Prevalence of the alternative lengthening of telomeres telomere maintenance mechanism in human cancer subtypes
CM Heaphy, AP Subhawong, SM Hong, MG Goggins, EA Montgomery, ...
The American journal of pathology 179 (4), 1608-1615, 2011
Intravenous infusion of a replication-selective adenovirus (ONYX-015) in cancer patients: safety, feasibility and biological activity
J Nemunaitis, C Cunningham, A Buchanan, A Blackburn, G Edelman, ...
Gene therapy 8 (10), 746-759, 2001
Prostate cancer, version 2.2019, NCCN clinical practice guidelines in oncology
JL Mohler, ES Antonarakis, AJ Armstrong, AV D’Amico, BJ Davis, T Dorff, ...
Journal of the National Comprehensive Cancer Network 17 (5), 479-505, 2019
PTEN protein loss by immunostaining: analytic validation and prognostic indicator for a high risk surgical cohort of prostate cancer patients
TL Lotan, B Gurel, S Sutcliffe, D Esopi, W Liu, J Xu, JL Hicks, BH Park, ...
Clinical cancer research 17 (20), 6563-6573, 2011
Prognostic value of p53 nuclear overexpression in patients with invasive bladder cancer treated with neoadjuvant MVAC.
AS Sarkis, DF Bajorin, VE Reuter, HW Herr, G Netto, ZF Zhang, ...
Journal of clinical oncology 13 (6), 1384-1390, 1995
A distinctive subset of PEComas harbors TFE3 gene fusions
P Argani, S Aulmann, PB Illei, GJ Netto, J Ro, H Cho, S Dogan, M Ladanyi, ...
The American journal of surgical pathology 34 (10), 1395-1406, 2010
Changing pattern of expression of the epidermal growth factor receptor and transforming growth factor alpha in the progression of prostatic neoplasms.
HI Scher, A Sarkis, V Reuter, D Cohen, G Netto, D Petrylak, P Lianes, ...
Clinical Cancer Research 1 (5), 545-550, 1995
Intratumoral injection of INGN 241, a nonreplicating adenovector expressing the melanoma-differentiation associated gene-7 (mda-7/IL24): biologic outcome in advanced cancer …
AW Tong, J Nemunaitis, D Su, Y Zhang, C Cunningham, N Senzer, ...
Molecular therapy 11 (1), 160-172, 2005
Rb loss is characteristic of prostatic small cell neuroendocrine carcinoma
HL Tan, A Sood, HA Rahimi, W Wang, N Gupta, J Hicks, S Mosier, ...
Clinical cancer research 20 (4), 890-903, 2014
A model to predict severe HCV‐related disease following liver transplantation
M Berenguer, J Crippin, R Gish, N Bass, A Bostrom, G Netto, J Alonzo, ...
Hepatology 38 (1), 34-41, 2003
Liver transplant-associated graft-versus-host disease
DM Smith, E Agura, G Netto, R Collins, M Levy, R Goldstein, ...
Transplantation 75 (1), 118-126, 2003
Liver transplantation for hepatitis C: recurrence and disease progression in 300 patients
G Testa, JS Crippin, GJ Netto, RM Goldstein, LW Jennings, BS Brkic, ...
Liver Transplantation 6 (5), 553-561, 2000
TERT promoter mutations occur early in urothelial neoplasia and are biomarkers of early disease and disease recurrence in urine
I Kinde, E Munari, SF Faraj, RH Hruban, M Schoenberg, T Bivalacqua, ...
Cancer research 73 (24), 7162-7167, 2013
The system can't perform the operation now. Try again later.
Articles 1–20